Mind Medicine (MindMed) Inc MNMD

Alternate Symbol(s): N.MMED.WA | N.MMED.WR | N.MMED.WS | N.MMED

Healthcare

Mind Medicine (MindMed) Inc. is a clinical-stage biopharmaceutical company, which is engaged in developing products to treat brain health disorders. It is developing a pipeline of product candidates, with and without acute perceptual effects, targeting neurotransmitter pathways. This specifically includes pharmaceutically optimized product candidates derived from the psychedelic and empathogen drug classes, including MM-120 and MM-402, the Company's product candidates. MM120, is a proprietary, pharmaceutically optimized form of lysergide D-tartrate that it is developing for the treatment of generalized anxiety disorder (GAD). MM-120 is also being studied in a subperceptual repeat administration dosing regimen for the treatment of attention deficit hyperactivity disorder (ADHD). MM-402, also referred to as R(-)-MDMA, is the Company's form of the R-enantiomer of 3,4-methylenedioxymethampheta (MDMA), which the Company is developing for the treatment of autism spectrum disorder (ASD).

NDAQ:MNMD - Post by User

Mind Medicine (MindMed) Inc

Bullboard Posts

Post by josameyeron Aug 20, 2010 9:59am

585 Views

Post# 17368538

insiders buing

N ice to see Derrick Gill buying 20-000 share in the public market at 1..23.transaction date August 11. Check Sedar for more insider buing.What we need is a public awareness regarding Brigus.Any ideas how they can obtain the biggest bang for a buck. at a reasonable price. As a long time shareholder of Apollo now Brigus, I believe that we are in for some exitement soon.For those that do not like Brigus , please find some other stock that you may like, and post there.Underground development is on track and we will have some results soon As always DYODD.To all Brigus shareholders have a great day.Cheers Josa.

Bullboard Posts

Level up your trading with BMO InvestorLine’s enhanced features